Targeted Nanotechnology

Anindita Behera is associated with Amity Institute of Pharmacy, Amity University, Kolkata, in the Department of Pharmaceutical Chemistry as Professor. She earned her master's degree from Pune University, India, and completed her PhD at Siksha 'O' Anusandhan Deemed to be University. Dr. Behera has developed innovative analytical methods for drug formulations used in AIDS treatment and is currently engaged in green synthesis of nanomaterials targeting various life-threatening diseases. With over 18 years of experience in research and academia, she has published numerous research and review articles in peer-reviewed journals. She has also contributed chapters to books published by major international publishers and has authored two books. Dr. Behera has guided three PhD scholars, sixteen postgraduate students, and forty-five undergraduate students in their research pursuits. Santwana Padhi serves as Scientific Communication Manager at Publication Practice Counsel, USA. She holds a PhD in Pharmaceutics from Jamia Hamdard University, specializing in cancer nanotherapeutics. Her research focuses on preclinical and clinical investigations of drug-loaded targeted nanosystems designed to enhance solid tumor treatment. Before her doctoral studies, she gained hands-on experience as a Research Assistant at the National Institute of Immunology (NII), honing her skills in formulation science. Following her PhD, she worked as a Medical Science Liaison (MSL) at Biocon, contributing to advancements in oncology and dermatology. Later, she joined the KIIT-Technology Business Incubator as Scientific Officer, where she played a key role in supporting entrepreneurial initiatives among young researchers and securing funding for technology development and commercialization. As a Senior Medical Writer at Reseapro Scientific Services, she has contributed to more than 50 publications, medical communication materials, and regulatory documents. Additionally, she has co-edited one book published by Springer Nature. Dr. Padhi has received numerous accolades, including the Senior Research Fellowship (SRF) from ICMR, Junior Research Fellowship (JRF) from DBT, and the Award of Excellence for Scientific Contribution from Jamia Hamdard University for two consecutive years.

• Chapter 1: Cancer: Cellular and Molecular Basis. Chapter 2: Emerging phytoconstituents from the natural origin in the battle against cancer: overview of molecular mechanisms. Chapter 3: Passive and active targeting strategies for delivery of phytochemical entrapped nanosystems for cancer. Chapter 4: Use of phytochemical entrapped nanosystems for cancer. Chapter 5: Nano-enabled system for delivery of camptothecin as an anticancer agent. Chapter 6: Nano-enabled systems for the delivery of berberine. Chapter 7: Nano-enabled systems for the delivery of Paclitaxel as anticancer agents. Chapter 8: Anticancer nano-drug delivery cargos of artemisinin. Chapter 9: Nano-enabled systems for the delivery of vinca alkaloids as anticancer agent. Chapter 10: Nano-enabled systems for the delivery of hesperidin as anticancer agents. Chapter 11: Nano-enabled systems for the delivery of thymoquinone as anticancer agents. Chapter 12: Nano-enabled systems for delivery of epigallocatechin gallate as anticancer agents. Chapter 13: Nano-enabled system for delivery of quercetin as anticancer agent. Chapter 14: Nano-enabled systems for the delivery of curcumin as an anticancer agent. Chapter 15: Nano-enabled systems for the delivery of resveratrol as an anticancer agent. Chapter 16: Nano-enabled systems for the delivery of cannabinoids as anticancer agent. Chapter 17: Nano-enabled systems for the delivery of anthracyclines as anticancer agents. Chapter 18: Nano-enabled systems for the delivery of different essential oils as an anticancer agent. Chapter 19: Nano-enabled systems for the delivery of carotenoids as anticancer agents. Chapter 20: Nano-enabled systems for the delivery of Docetaxel as anticancer agents. Chapter 21: Co-delivery of natural drugs with other anticancer drugs entrapping nanodelivery systems for cancer. Chapter 22: Drug delivery systems entrapping natural drugs and derivatives: Recent advancements and future challenges. Chapter 23: Phytomolecules targeting resistant cancer cells through nano-delivery systems. Chapter 24: Prevention is better than cure – the role of phytomolecules in the prevention of cancer development.